Diagnosis and Treatment of Adenocarcinomas and Squamous Cell Carcinomas of the Lung
November 5, 2016
Learning Objectives
- Discuss the range of genetic variants in NSCLC and how they are used to select targeted agents for patients with NSCLC
- Identify current diagnosis and treatment paradigms for patients with squamous cell NSCLC
- Identify and manage adverse events that occur with the use of immunotherapies across all subtypes of NSCLC
Gaylord National Hotel
National Harbor, MD
United States
Available Credit
- 1.00 ACPE
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance
- 1.00 ANCC